| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 10/02/2008 | WO2008116262A1 Methods and compositions for treating prostate cancer |
| 10/02/2008 | US20080242666 e.g. (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-(1-ethylpropyl)-1-[2(hydroxymethyl)benzyl]-piperazine-2,5-dione; preparation by cyclization |
| 10/02/2008 | US20080241960 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders |
| 10/02/2008 | US20080241099 Inhibitors of MBP 85-99 or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell clones; multiple sclerosis; rheumatoid arthritis; solid phase synthesis; kits |
| 10/02/2008 | CA2684655A1 Oral pharmaceutical preparation for colon-specific delivery |
| 10/02/2008 | CA2681917A1 Methods and compositions for treating prostate cancer |
| 10/01/2008 | EP1975168A1 Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation |
| 10/01/2008 | EP1975159A1 2,3,4,9-Tetrahydro-1H-carbazoles |
| 10/01/2008 | EP1973555A2 Processes for obtaining lignan extracts and compositions containing the lignan extracts |
| 10/01/2008 | EP1973524A1 Concentrated liquid thyroid hormone composition |
| 10/01/2008 | EP1331935B1 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 10/01/2008 | CN101278079A 药物设计方法 Drug Design Methods |
| 10/01/2008 | CN101274043A Chinese medicinal composite for curing Sheehans syndrome and method of preparing the same |
| 10/01/2008 | CN101274012A Composition of Prunella plant extracts, preparation and pharmaceutical use thereof |
| 10/01/2008 | CN100422211C Antagonistic analogs in GH-RH inhibiting IGF-I and -II |
| 10/01/2008 | CN100422186C Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 10/01/2008 | CN100421667C Method for treating and preventing hyperparathyroidism |
| 10/01/2008 | CN100421652C Pharmaceutical compsns. of conjugated estrogens and methods for their use |
| 09/30/2008 | US7429559 Controlled release composition and method of producing the same |
| 09/30/2008 | CA2453646C 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 09/25/2008 | WO2008115413A1 Aromatase inhibitors for the treatment of mastalgia |
| 09/25/2008 | WO2008114819A1 Novel adenine compound |
| 09/25/2008 | WO2008114679A1 Bone metabolism ameliorating agent |
| 09/25/2008 | WO2008114536A1 Dehydroepiandrosterone production promoter and use thereof |
| 09/25/2008 | WO2008060391A3 2- [l-phenyl-5-hydr0xy-4alpha-methyl-hexahydr0cycl0penta[f] indaz0l-5-yl] ethyl phenyl derivatives as glucocorticoid receptor ligands |
| 09/25/2008 | US20080234467 Modifying amino acid sequences conjugate comprising: coupling N- alpha -protected amino acid to an immobilized peptide sequence, deprotecting sequence, cleaving peptide conjugate, recovering product |
| 09/25/2008 | US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 09/25/2008 | US20080234340 Synthesis and characterization of polymorph form II of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-YL)thiazol-4-YL)benzonitrile |
| 09/25/2008 | US20080233649 Progenitor cells; serum-free; differentiation; cloning |
| 09/25/2008 | US20080233198 Administering microcapsules containing a peptide and copolymer incorporating triethyl citrate, tributyl citrate or acetyl tributyl citrate; reducing initial release, providing steady release over time |
| 09/24/2008 | EP1971602A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 09/24/2008 | EP1971325A2 Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
| 09/24/2008 | EP1865938A4 Dosing regimes for trans-clomiphene |
| 09/24/2008 | EP1572299B1 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 09/24/2008 | EP1383578B1 Single dose aromatase inhibitor for treating infertility |
| 09/24/2008 | CN101272782A Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| 09/24/2008 | CN101270139A Common camellia flavone glycosides A with estrogen liveness, preparation method and application thereof |
| 09/24/2008 | CN101269205A Medicament combination for recuperating qi-blood, dissolving stasis and preparation method thereof |
| 09/24/2008 | CN101269190A Blood circulation activating and stasis removing, and Qi-smoothening blood-nourishing medicament combination and preparation method thereof |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427591 Suppression of immune response via inhibition of cathepsin S |
| 09/23/2008 | CA2480800C Inhibitors of akt activity |
| 09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |
| 09/23/2008 | CA2266479C Vitamin d analogues |
| 09/23/2008 | CA2206008C Method for the synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide |
| 09/18/2008 | WO2008112498A2 Synthesis and characterization of polymorph form ii of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile |
| 09/18/2008 | WO2008112495A1 Synthesis and characterization of polymorph form iii of 4-(2,(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile |
| 09/18/2008 | WO2008111573A1 Growth hormone secretion stimulator |
| 09/18/2008 | US20080227954 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
| 09/18/2008 | US20080227869 Substituted nitrobenzene derivatives as pharmaceutical and other uses thereof |
| 09/18/2008 | US20080227850 Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| 09/18/2008 | US20080227814 Ethanolamine derivatives such as 6-hydroxy-1-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-(p-methylsulfonylphenyl)tetralin and 6-hydroxy-2-(p-(trifluoromethyl)phenyl)-3-(p-(2-(1-piperidinyl)ethoxy)benzoyl)benzothiophene; treating endometriosis and uterine leiomyoma. |
| 09/18/2008 | US20080227770 Benzoxazepine Compound |
| 09/18/2008 | US20080227763 Administering hormone replacement therapy by applying a gel of Nomegestrol or Nomegestrol acetate to the skin; restoring genital bleeding in menopausal women |
| 09/18/2008 | CA2680818A1 Growth hormone secretion stimulator |
| 09/17/2008 | EP1970072A1 Use of GLP-2 peptides for the treatment of hyperparathyroidism |
| 09/17/2008 | EP1969126A1 Method of detecting and reducing boar taint using nuclear receptors |
| 09/17/2008 | EP1968559A2 Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
| 09/17/2008 | EP1305334B1 Urocortin proteins and uses thereof |
| 09/17/2008 | EP1297838B1 Pralmorelin-containing nasal drop preparations |
| 09/17/2008 | EP0712303B2 Skin patches comprising testosterone and optionally estrogen |
| 09/17/2008 | CN101267809A Sugar coatings and methods therefor |
| 09/17/2008 | CN101264158A Application of Chinese medicine composing prescription in preparing medicaments for treating metabolic syndrome |
| 09/17/2008 | CN101264122A Hypericum extract, its making method and medicinal composition and use for treating diabetes |
| 09/17/2008 | CN101264095A Application of polydatin in preventing and controlling obesity and relieving insulin resistance |
| 09/17/2008 | CN101264073A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 09/17/2008 | CN101264072A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 09/17/2008 | CN100418965C Imidazopyridine derivatives |
| 09/17/2008 | CN100418555C Medicine for treating sub health and endocrine disorder and preparing method |
| 09/16/2008 | US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders |
| 09/16/2008 | US7425566 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 09/16/2008 | US7425532 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/16/2008 | US7425331 Protein A methods of use |
| 09/12/2008 | WO2008070507A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/12/2008 | WO2006065968A8 The uses of estrogen beta agonists to treat cognitive diseases |
| 09/11/2008 | US20080221207 Use of specific cyklolignans |
| 09/11/2008 | US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation |
| 09/11/2008 | US20080221073 Nitrooxy Derivatives of Glucocorticoids |
| 09/11/2008 | US20080221021 Novel Corticotropin-Releasing Factor Receptor 1 (Crfr1) Agonist |
| 09/11/2008 | US20080220095 Red blood cells loaded with s-nitrosothiol and uses therefor |
| 09/11/2008 | DE102007011486A1 Arzneimittel umfassend wenigstens ein Gestagen A pharmaceutical composition comprising at least one progestin |
| 09/10/2008 | EP1646389B1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 09/10/2008 | EP1633883B1 Method for assaying lkb1 phosphorylation activity |
| 09/10/2008 | EP0871376B1 Use of locally administered lysine for enhancing vascular fonction |
| 09/10/2008 | CN101263135A Modulators of metabolism and the treatment of disorders related thereto |
| 09/10/2008 | CN101263119A Novel 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 09/09/2008 | US7423052 Piperidine compounds for use as orexin receptor antagoinst |
| 09/09/2008 | US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 09/09/2008 | CA2362769C Microcapsules for sustained release of drugs |
| 09/04/2008 | WO2008106600A1 Bazedoxifene bis-phosphorates |
| 09/04/2008 | WO2008105384A1 Citrulline-containing tablet |
| 09/04/2008 | WO2008104124A1 Screening method of combination pharmaceuticals, pharmaceuticals obtained by the method and uses thereof |
| 09/04/2008 | WO2007139826A3 Method for elevating prolactin in mammals |
| 09/04/2008 | US20080214781 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 09/04/2008 | US20080214612 for therapy of endometriosis and/or uterine leiomyoma/leiomyomata; 1-(2-{4-[2-(4-Methanesulfonyl-phenyl)-6-methoxy-naphthalen-1-yloxy]-phenoxy}-ethyl)-piperidine |
| 09/04/2008 | US20080214609 compounds that agonize the membrane-associated estrogen receptor identified herein act as neuroprotectants to reduce neuronal cell death in response to ischemic stroke and inhibit reperfusion injury |
| 09/04/2008 | US20080214543 Antiandrogen; prostate cancer; excellent oral pharmacokinetics |
| 09/04/2008 | CA2678032A1 Bazedoxifene bis-phosphorates |
| 09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
| 09/03/2008 | EP1964571A1 Treatment of endothelial dysfunction in diabetic patients |